World Journal of Gastrointestinal Oncology is published by Baishideng Publishing Group (BPG). Choosing BPG’s series of journals means placing compliance with scientific norms and ethical standards at the forefront.

World Journal of Gastrointestinal Oncology is a rigorously peer-reviewed, open-access academic journal dedicated to publishing original, high-quality research findings in the field of gastrointestinal oncology, including clinical, translational, and basic studies, as well as research involving artificial intelligence. The journal focuses on, but is not limited to, the following areas: Islet cell adenoma, liver cell adenoma, adenomatous polyposis coli, appendiceal neoplasms, bile duct neoplasms, biliary tract neoplasms, hepatocellular carcinoma, islet cell carcinoma, pancreatic ductal carcinoma, cecal neoplasms, colonic neoplasms, colorectal neoplasms, hereditary nonpolyposis colorectal neoplasms, common bile duct neoplasms, duodenal neoplasms, esophageal neoplasms, gallbladder neoplasms, Gardner syndrome, gastrinoma, gastrointestinal neoplasms, glucagonoma, ileal neoplasms, insulinoma, intestinal neoplasms, jejunal neoplasms, liver neoplasms, experimental liver neoplasms, pancreatic neoplasms, peritoneal neoplasms, rectal neoplasms, sigmoid neoplasms, somatostatinoma, stomach neoplasms, and vipoma. Types of articles published by the journal include clinical study, basic study, case report, editorial, review, minireview, systematic review, meta-analysis, guidelines, and correspondence. The journal sincerely welcomes experts and scholars to submit original research manuscripts. Each submission will be peer-reviewed by at least two independent reviewers, who will critically assess its novelty, significance, and reproducibility, as well as any flaws in experimental design and data processing, in order to provide authors with meaningful peer review reports. The journal adheres to editorial policies, peer-review processes, editorial processes, and publication ethics guidelines developed by the editorial office in accordance with the Committee on Publication Ethics, the International Committee of Medical Journal Editors, and the World Association of Medical Editors. These principles form the foundation for delivering high-quality services to authors, providing high-quality academic content to readers, and supporting the advancement of clinical practice. Submit an Article >>

The 2025 edition of Journal Citation Reports® cites the 2024 journal impact factor (JIF) for WJGO as 2.5; JIF without journal self cites: 2.4; 5-year JIF: 2.7; JIF Rank: 68/147 in gastroenterology and hepatology; JIF Quartile: Q2; and 5-year JIF Quartile: Q3; JIF Rank: 188/326 in oncology; JIF Quartile: Q3; and 5-year JIF Quartile: Q3.

The WJGO’s CiteScore for 2024 is 3.3 and Scopus CiteScore rank 2024: Gastroenterology is 89/173; Oncology is 235/415. 

• Winnie Yeo, FRCP, FRCPE, MD, Professor, (E-mail: winnie@clo.cuhk.edu.hk) Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong 999077, China